ACO2 Antibody (Rabbit mAb) [E24J9]

CatNo: F5369

    Application: Reactivity:
    • Lane 1: Hela, Lane 2: K562, Lane 3: Jurkat, Lane 4: Mouse Liver
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    推奨WB希釈率: 1:10000

    使用情報

    Dilution
    1:10000 - 1:50000
    1:100 - 1:250
    Application
    WB, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    85 kDa 90 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human kidney tissue; Human fetal heart tissue; Mouse liver tissue; HeLa cells; K562 cells; HAP1 cells; Jurkat cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:10000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    ACO2 Antibody (Rabbit mAb) [E24J9] detects endogenous levels of total ACO2 protein.
    タンパク質の局在
    ミトコンドリア
    Uniprot ID
    Q99798
    Clone
    E24J9
    Synonym(s)
    Aconitase, Citrate hydro-lyase, ACO2
    Background
    Aconitase 2 (ACO2) is the mitochondrial isoform of the aconitase/IPM isomerase family that catalyzes the reversible isomerization of citrate to isocitrate via cis‑aconitate in the tricarboxylic acid cycle and functions as a [4Fe–4S] iron–sulfur dehydratase whose activity is tightly coupled to both oxidative metabolism and mitochondrial iron homeostasis. The enzyme is encoded in the nucleus, imported into the mitochondrial matrix and organized into four domains with an α/β‑alternating fold that buries a single active site in the core of the protein; three cysteine residues coordinate a [4Fe–4S] cluster that does not participate in electron transfer but instead orients and activates the substrate hydroxyl group for elimination and readdition, with citrate or isocitrate binding at this cluster and conserved residues such as His101, His167, Asp100, Glu262 and Ser642 orchestrating proton transfer and intermediate formation during the two‑step dehydratase/rehydratase mechanism. The iron–sulfur cluster is highly sensitive to oxidation by reactive oxygen and nitrogen species, and exposure to mitochondrial ROS causes loss of iron from the cluster, conversion to an inactive [3Fe–4S] state and degradation of oxidatively modified ACO2 by the Lon protease PRSS15, so that ACO2 acts as both a metabolic enzyme and a redox‑sensitive node linking oxidative stress to TCA cycle flux and mitochondrial protein turnover. Reviews of mitochondrial aconitase emphasize that ACO2 is one of the main targets of mitochondrial ROS/RNS and plays important roles in maintaining the intracellular iron pool and mitochondrial DNA stability, with inactivation or dysfunction of ACO2 leading to altered bioenergetics, disturbed iron homeostasis and increased susceptibility to neurodegenerative diseases such as Friedreich’s ataxia, Parkinson’s disease and Alzheimer’s disease, in which decreased Fe‑S protein activity and mitochondrial iron accumulation are common features. In Friedreich’s ataxia, frataxin mutation is associated with deficiency of Fe‑S cluster–containing respiratory complexes I–III and aconitase in cardiac tissue and yeast models, supporting a mechanism in which mitochondrial iron overload and oxidative damage compromise ACO2 activity and contribute to cardiomyopathy and neurodegeneration, and similar Fe‑S vulnerability is seen in other mitochondrial disorders. Cancer studies show that ACO2 participates in metabolic rewiring: ACO2 expression is reduced in several tumors, and forced ACO2 overexpression in MCF‑7 breast cancer cells impairs proliferation, redirects pyruvate toward mitochondrial oxidation, weakens Warburg‑like glycolytic features and promotes ROS‑dependent FoxO1‑mediated autophagy and mitophagy, indicating that ACO2 levels influence the balance between glycolytic and oxidative metabolism and can reveal metabolic vulnerabilities in ACO2‑associated malignancies. Genetic inhibition of mitochondrial aconitase in C. elegans and mammalian cells lowers oxaloacetate levels, enhances the mitochondrial unfolded protein response via ATFS‑1 and increases immunity against pathogenic bacteria, showing that ACO2‑dependent metabolism suppresses innate immune activation and that targeting ACO2 can modulate mitochondrial UPR and host defense.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください